Clinical and biological significance of serum tumor markers in adult T-cell leukemia

Leukemia and Lymphoma

Volumn 22, Issue 5-6, 1996, Pages 415-419

  Sadamori, Naoki ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adult T cell leukemia; Biological indicator; Clinical indicator; Serum tumor marker

Indexed keywords

BETA 2 MICROGLOBULIN; CALCIUM; FERRITIN; LACTATE DEHYDROGENASE; PARATHYROID HORMONE RELATED PROTEIN; THYMIDINE KINASE; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

CALCIUM BLOOD LEVEL; CELL NUCLEUS; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SHORT SURVEY; SURVIVAL; T CELL LEUKEMIA; THROMBOCYTE COUNT;

EID: 0029845325     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054779     Document Type: Short Survey

References (59)

1. Takatsuki, K., Uchiyama, T., Sagawa, K. and Yodoi, J. (1977) Adult T cell leukemia in Japan. In: Seno, S., Takaku, F. and Irino, S. eds. Topics in Hematology. pp. 73-77. Amsterdam: Excerpta Medica.
2. Takatsuki, K., Yamaguchi, K. and Hattori, T. (1990) Adult T-cell leukemia. In: Henderson, E. S. and Lister, T. A. eds. 5th edn. pp. 661-667. Philadelphia: W. B. Saunders Company.
3. Shimoyama, M. and the Lymphoma Study Group (984-87). (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. Br. J. Haematol., 79, 428-437.
4. Shimoyama, M., Ota, K., Kikuchi, M., Yunoki, K., Konda, S., Takatsuki, K., Ichimaru, M., Tominaga, S., Tsugane, S., Minato, K., Tobinai, K., Oyama, A., Hisano, S., Matsumoto, M., Takiguchi, T., Yamaguchi, K., Kinoshita, K., Tajima, K. and Suemasu, K. for the Lymphoma Study Group (1981-1983). (1988) Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. J. Clin. Oncol, 6, 1088-1097.
5. Tsukasaki, K., Ikeda, S., Murata, K., Maeda, T., Atogami, S., Sohda, H., Momita, S., Jubashi, T., Yamada, Y., Mine, M., Kamihira, S. and Tomonaga, M. (1993) Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma. Leuk. Res., 17, 157-166.
6. Yamada, Y., Murata, K., Kamihira, S., Atogami, S., Tsukasaki, K., Sohda, H., Yanagisako, T., Momita, S., Jubashi, T., Amagasaki, T., Kuriyama, K., Oyakawa, Y., Tagawa, M., Kinoshita, K., Ichimaru, M. and Tomonaga, M. (1991) Prognostic significance of the proportion of Ki-67-positive cells in adult T-cell leukemia. Cancer, 67, 2605-2609.
7. Wroblewski, F. and La Due, J. S. (1955) Lactic dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med., 90, 210-213.
8. Bierman, H. R., Hill, B. R., Reinhardt, L. and Emory, E. (1957) Correlation of serum lactic dehydrogenase activity with the clinical status of patients with cancer, lymphomas and the leukemias. Cancer Res., 17, 660-667.
9. Arseneau, J. C., Canellos, G. P., Banks, P. M., Berard, C. W., Gralnick, H. R. and De Vita, V. T. Jr. (1975) American Burkitt's lymphoma: A clinicopathologic study of 30 cases. 1. Clinical factors relating to prolonged survival. Am. J. Med., 58, 314-321.
10. Brereton, H. D., Simon, R. and Pomeroy, T. C. (1975) Pretreatment serum lactate dehydrogenase predicting metastatic spread in Ewing's sarcoma. Ann. Intern. Med., 83, 352-354.
11. Ferraris, A. M., Giuntini, P. and Gaetani, G. F. (1979) Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas. Blood, 54, 928-932.
12. Schneider, R. J., Seibert, K., Passe, S., Little, C., Gee, T., Lee, B. J., Mike, V. and Young, C. W. (1980) Prognostic significance of serum lactate dehydrogenase in malignant Iymphoma. Cancer, 46, 139-143.
13. Kinoshita, K., Ikeda, S., Yamada, Y., Amagasaki, T., Momita, S., Toriya, K., Ichimaru, M. and Kamihira, S. (1983) Some clinical aspects of adult T-cell leukemia-lymphoma (ATLL). (1) Duration of survival of adult T-cell leukemia (ATL) and some useful parameters (in Japanese). Jpn. J. Clin. Hematol., 24, 818-825.
14. Tamura, K., Nagamine, N., Araki, Y., Seita, M., Okayama, A., Kawano, K., Tachibana, N., Tsuda, K., Kuroki, Y., Narita, H., Inoue, S., Suzumiya, J., Sumiyoshi, A., Aratake, Y., Ohtaki, S., Torigoe, J. and Kawachi, J. (1986) Clinical analysis of 33 patients with adult T-cell leukemia (ATL) - diagnostic criteria and significance of high- and low-risk ATL. Int. J. Cancer, 37, 335-341.
15. Gronowitz, J. S., Steinholtz, L., Källander, C. F. R., Hagberg, H. and Bergh, J. (1986) Serum deoxythymidine kinase in small cell carcinoma of the lung: relation to clinical features, prognosis, and other biochemical markers. Cancer, 58, 111-118.
16. Correale, M. and Abbate, I. (1990) Thymidine kinase (TK) as a tumor marker in breast cancer. Tumor Biol., 11, 76.
17. Robertson, J. F., O'Neill, K. L., Thomas, M. W., McKenna, P. G. and Blamey, R. W. (1990) Thymidine kinase in breast cancer. Br. J. Cancer, 62, 663-667.
18. Fischbach, W., Schwarz, W. C. and Jany, B. (1989) Neuron-specific enolase and thymidine kinase as an aid to the diagnosis and treatment monitoring of small cell lung cancer. Cancer, 63, 1143-1149.
19. Lewenhaupt, A., Ekman, P., Eneroth, P. and Nilsson, B. (1990) Tumor markers as prognostic aids in prostatic carcinoma. Br. J. Urol., 66, 182-187.
20. Hagberg, H., Gronowitz, J. S., Killander, A., Källander, C. F. R., Simonsson, B., Sundström, C. and Öberg, G. (1984) Serum thymidine kinase in acute leukemia. Br. J. Cancer, 49, 537-540.
21. Morgan, M. A. M., Cooper, E. H., Bailey, C. C., Gronowitz, J. S. and Källander, C. F. R. (1985) Serum deoxythymidine kinase in acute lymphoblastic leukaemia in children. Tumor Diagn. Ther., 6, 155-158.
22. Russo, S. A., Harris, M. B. and Greengard, O. (1987) Lymphocyte thymidine kinase and treatment response in acute lymphocytic leukemia. Leuk. Res., 11, 149-154.
23. Archimbaud, E., Vigreux, B., Tigaud, J.-D., Maupas, J., Guyotat, D., Viala, J.-J. and Fiere, D. (1988) Serum thymidine kinase in acute non-lymphocytic leukemia. Leukemia, 2, 245-246.
24. Doi, S., Naito, K. and Yamada, K. (1990) Serum deoxythymidine kinase as a progressive marker of hematological malignancy. Nagoya J. Med. Sci., 52, 19-26.
25. Sadamori, N., Ichiba, M., Mine, M., Hakariya, S., Hayashibara, T., Itoyama, T., Nakamura, H., Tomonaga, M. and Hayashi, K. (1995) Clinical significance of serum thymidine kinase in adult T-cell leukaemia and acute myeloid leukaemia. Br. J. Haematol., 90, 100-105.
26. Ellims, P. H. (1981) Thymidine kinase isozymes in chronic lymphocytic leukemia. Br. J. Haematol., 49, 479-481.
27. Källander, C. F. R., Simonsson, B., Hagberg, H. and Gronowitz, J. S. (1984) Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia. Cancer, 54, 2450-2455.
28. Ellims, P. H., Eng Gan, T., Medley, G. and van der Weyden, M. B. (1981) Prognostic relevance of thymidine kinase in adult non-Hodgkin's Iymphoma. Blood, 58, 926-930.
29. Gronowitz, J. S., Hagberg, H., Källander, C. F. R. and Simonsson, B. (1983) The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma. Br. J. Cancer, 47, 487-495.
30. Hallek, M., Emmerich, B., Strohmeyer, S., Busch, R., Reichle, A. and Senekowitsch, R. (1988) Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors. Klin. Wochenschr., 66, 718-723.
31. Hagberg, H., Glimelius, B., Gronowitz, J. S., Killander, A., Källander, C. F. R. and Schröder, T. (1984) Biochemical markers in non-Hodgkin's lymphoma stages III and IV and prognosis: a multivariate analysis. Scand. J. Haematol., 33, 59-67.
32. Martinsson, U., Glimelius, B., Hagberg, H. and Sundström, C. (1988) Prognostic relevance of serum-markers in relation to histopathology, stage and initial symptoms in advanced low-grade non-Hodgkin lymphomas. Eur. J. Haematol., 40, 289-298.
33. Martinsson, U., Glimelius, B., Hagberg, H. and Sundström, C. (1989) Primarily asymptomatic low-grade non-Hodgkin lymphomas: prediction of symptom-free survival and total survival. Eur. J. Haematol., 43, 332-338.
34. Eriksson, B., Hagberg, H., Glimelius, B., Sundström, C. and Gronowitz, J. S. (1985) Serum thymidine kinase as a prognostic marker in Hodgkin's disease. Acta Radiol. Oncol., 24, 167-171.
35. Luoni, R., Ucci, G., Raccardi, A., Gobbi, P., Avato, F. M., Vignale, C. and Ascari, E. (1992) Serum thymidine kinase in monoclonal gammopathies: a prospective study. Cancer, 69, 1368-1372.
36. Simonsson, B., Källander, C. F. R., Brenning, G., Killander, A., Åhre, A. and Gronowitz, J. S. (1985) Evaluation of serum deoxythymidine kinase as a marker in multiple myeloma. Br. J. Haematol, 61, 215-224.
37. Simonsson, B., Källander, C. F. R., Brenning, G., Killander, A., Gronowitz, J. S. and Bergström, R. (1988) Biochemical markers in multiple myeloma: a multivariate analysis. Br. J. Haematol., 69, 47-53.
38. Ucci, G., Riccardi, A., Luoni, R., Spriano, P., Merlini, G., Danova, M., Cassano, E., Molinari, E. and Ascari, E. (1987) Serum thymidine kinase and β2-microglobulin in monoclonal gammopathies. Tumori, 73, 445-449.
39. Hallek, M., Wanders, L., Strohmeyer, S. and Emmerich, B. (1992) Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications. Ann. Hematol., 65, 1-5.
40. Sadamori, N., Ikeda, S., Yamaguchi, K., Mine, M., Hakariya, S., Kinoshita, H., Hayashi, K., Nakamura, T., Nagataki, S. and Ichiniaru, M. (1991) Serum deoxythymidine kinase in adult T-cell leukemia-lymphoma and its related disorders. Leuk. Res., 15, 99-103.
41. Kagimoto, T., Oda, T., Nakakuma, H., Kawaguchi, T., Hidaka, M., Horikawa, K., Matsuzaki, H. and Takatsuki, K. (1991) Serum deoxythymidine kinase activity in adult T-cell leukemia (in Japanese). Jpn. J. Cancer Chemother., 18, 63-67.
42. Suva, L. J., Winslow, G. A., Wettenhall, R. E. H., Hammonds, R. G., Moseley, J. M., Diefenbach-Jagger, H., Rodda, C. P., Kemp, B. E., Rodriguez, H., Chen, E. Y., Hudson, P. J., Martin, T. J. and Wood, W. I. (1987) A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science, 237, 893-896.
43. Moseley, J. M., Kubota, M., Diefenbach-Jagger, H., Wettenhall, R. E. H., Kemp, B. E., Suva, L. J., Rodda, C. P., Ebeling, P. R., Hudson, P. J., Zajac, J. D. and Martin, T. J. (1987) Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc. Natl. Acad. Sci. U.S.A., 84, 5048-5052.
44. Strewler, G. J., Stern, P. H., Jacobs, J. W., Eveloff, J., Klein, R. F., Leung, S. C., Rosenblatt, M. and Nissenson, R. A. (1987) Parathyroid hormone-like protein from human renal carcinoma cells: structural and functional homology with parathyroid hormone. J. Clin. Invest., 80, 1803-1807.
45. Motokura, T., Fukumoto, S., Takahashi, S., Watanabe, T., Matsumoto, T., Igarashi, T. and Ogata, E. (1988) Expression of parathyroid hormone-related protein in a human T-cell lymphotropic virus type I-infected T-cell line. Biochem. Biophys. Res. Commun., 154, 1182-1188.
46. Ikeda, K., Okazaki, R., Inoue, D., Ohno, H., Ogata, E. and Matsumoto, T. (1993) Interleukin-2 increases production and secretion of parathyroid hormone-related peptide by human T cell leukemia virus type I-infected T cells: possible role in hypercalcemia associated with adult T cell leukemia. Endocrinol., 132, 2551-2556.
47. Moseley, J. M., Danks, J. A., Grill, V., Lister, T. A. and Horton, M. A. (1991) Immunocytochemical demonstration of PTHrP protein in neoplastic tissue of HTLV-1 positive human adult T cell leukaemia/lymphoma: implications for the mechanism of hypercalcemia. Br. J. Cancer, 64, 745-748.
48. Watanabe, T., Yamaguchi, K., Takatsuki, K., Osame, M. and Yoshida, M. (1990) Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene. J. Exp. Med., 172, 759-765.
49. Yamaguchi, K., Kiyokawa, T., Watanabe, T., Ideta, T., Asayama, K., Mochizuki, M., Blank, A. and Takatsuki, K. (1994) Increased serum levels of C-terminal parathyroid hormone-related protein in different diseases associated with HTLV-1 infection. Leukemia, 8, 1708-1711.
50. Sadamori, N., Mine, M. and Kasahara, H. (1995) Clinical and biological significance of serum parathyroid hormone-related protein in adult T-cell leukemia. Leukemia Res., 19, 229-230.
51. 2-microglobulin and its turnover on the cell membrane. Proc. Nail. Acad. Sci. USA., 71, 2123-2127.
52. Child, J. A. and Kushwaha, M. R. S. (1984) Serum beta 2-microglobulin in lymphoproliferative and myeloproliferalive diseases. Hematol Oncol., 2, 391-401.
53. 2-microglobulin in malignant lymphoma. Cancer, 51, 2220-2225.
54. 2-microglobulin and thymidine kinase in malig-nant lymphomas. Cancer Detec. Prev., 12, 125-131.
55. Späti, B., Child, J. A., Kerruish, S. M. and Cooper, E. H. (1980) Behaviour of β-microglobulin and acute phase reactant proteins in chronic lymphocytic leukaemia. Acta. Haematol., 64, 79-86.
56. 2-microglobulin in multiple myeloma. Eur. J. Cancer Clin. Oncol., 23, 1829-1832.
57. Bataille, R., Grenier, J. and Sany, J. (1984) Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment. A prospective study of 160 patients. Blood, 63, 468-176.
58. 2-microglobulin in serum of adult T cell leukemia. Leukemia, 9, 594-597.
59. Sadamori, N., Yamaguchi, K., Ikeda, S., Hakariya, S., Mine, M., Itoyama, T., Iwasaki, H., Kinoshita, H., Hayashi, K. and Ichimaru, M. (1990) Serum deoxythymidine kinase in adult T-cell leukemia and its related disorders (in Japanese). Jpn. J. Clin. Hematol., 31, 1812-1817.